Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East Tech Today.
Press releases published on May 12, 2025
Mineralys Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
May 12, 2025
– Pivotal Advance-HTN and Launch-HTN trials successfully achieved statistical significance in primary efficacy endpoints and demonstrated a favorable safety and tolerability profile – – Anticipate Explore-CKD Phase 2 trial to deliver topline data in Q2 …
Jasper Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
May 12, 2025
REDWOOD CITY, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting KIT to address mast cell driven …
FibroGen Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
May 12, 2025
Total consideration for the sale of FibroGen China to AstraZeneca now expected to be approximately $185 million, a $25 million increase from initial guidance Net cash held in China at closing now estimated to be approximately $100 million Transaction …
Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q1 Financial Results
GlobeNewswire
·
May 12, 2025
Completed enrollment in Phase 2 MaGic trial of DNTH103 in generalized Myasthenia Gravis (gMG) Top-line MaGic results anticipated in September 2025 to be the first of three catalysts for the DNTH103 neuromuscular franchise by YE’26 Phase 3 CAPTIVATE trial …
Neumora Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
May 12, 2025
On track to report topline data from NMRA-511 in Alzheimer’s disease agitation around the end of 2025 Resumed enrollment for KOASTAL-3 and -2 studies in March 2025; anticipate reporting topline major depressive disorder data from KOASTAL-3 in the first …
Aquestive Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
May 12, 2025
Submitted NDA for Anaphylm™ (epinephrine), the first and only oral sublingual film for patients with severe allergic reactions Advancing commercial readiness efforts with a planned Q1 2026 launch of Anaphylm, subject to FDA approval Company to host …
Assertio Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 12, 2025
First Quarter Total Net Product Sales of $26.0 Million, In Line with 2025 Outlook Provides Update on Long-Term Business Strategy Designed to Create Sustainable Near-Term Growth and Increased Long-Term Value LAKE FOREST, Ill., May 12, 2025 (GLOBE NEWSWIRE) …
Relmada Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
May 12, 2025
Positive initial Phase 2 proof-of-concept data for NDV-01 at AUA 2025 showing a 90% overall response rate at any time in non-muscle invasive bladder cancer (US prevalence 600K patients) The Phase 2 study for NDV-01 continues with updates at 6, 9 and 12 …
CompoSecure Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 12, 2025
Operating results in line with expectations Reiterating previously issued full-year 2025 guidance Completed spin-off of Resolute Holdings Management, Inc. (Nasdaq: RHLD) Accounting standards related to the spin-off require the Company to report results …
Syndax Pharmaceuticals Appoints Dr. Nicholas Botwood as Head of Research and Development and Chief Medical Officer
GlobeNewswire
·
May 12, 2025
- Dr. Nicholas Botwood comes to Syndax from BMS and brings 25 years of industry experience leading drug development, R…
Editas Medicine Announces U.S. Court of Appeals for the Federal Circuit Remands CRISPR Patent Interference to Patent Trial and Appeal Board
GlobeNewswire
·
May 12, 2025
CAMBRIDGE, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company, today announced that the U.S. Court of Appeals for the Federal Circuit affirmed-in-part and vacated-in-part the Patent Trial and …
MoonLake Immunotherapeutics Reports First Quarter 2025 Financial Results and Provides a Business Update
GlobeNewswire
·
May 12, 2025
MoonLake Immunotherapeutics Reports First Quarter 2025 Financial Results and Provides a Business Update Continued to make significant progress with the development of the Nanobody® sonelokimab across portfolio of indications, including Phase 3 studies in …
Siren Biotechnology to Present Universal AAV Immuno-Gene Therapy Data at the 2025 American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
GlobeNewswire
·
May 12, 2025
SAN FRANCISCO, May 12, 2025 (GLOBE NEWSWIRE) -- Siren Biotechnology Inc., pioneers of Universal AAV Immuno-Gene Therapy for Cancer, today announced that it will present new scientific data at the 2025 American Society of Gene and Cell Therapy (ASGCT) …
Pace-O-Matic presents inaugural Integrity Award to Larry Hilimire
GlobeNewswire
·
May 12, 2025
DULUTH, Ga., May 12, 2025 (GLOBE NEWSWIRE) -- Pace-O-Matic and its founder, Michael Pace, have presented the first-ever Integrity Award to Larry Hilimire, amusement industry legend and owner of Staunton Automatics in New York. The award was presented to …
ProvisionAi Launches Make-n-Ship—A Breakthrough AutoO2 Capability for Optimizing Factory Shipments in Tight Dock Environments
GlobeNewswire
·
May 12, 2025
FRANKLIN, Tenn., May 12, 2025 (GLOBE NEWSWIRE) -- ProvisionAi, with patented AI-powered transportation optimization, today announced the launch of Make-n-Ship, a powerful new capability in its AutoO2 platform. Designed specifically for factories with …
Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure
GlobeNewswire
·
May 12, 2025
TORONTO, May 12, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for infectious diseases and …
XRP News: Vaultro Finance Hits 10% of $VLT Softcap Within Hours — Investors Rush to Join the S&P 500 of Crypto
GlobeNewswire
·
May 12, 2025
SINGAPORE, May 12, 2025 (GLOBE NEWSWIRE) -- Vaultro Finance, the first decentralized index fund protocol on the XRP Ledger, has officially made its mark. Within just hours of launching the $VLT presale, the project has already raised over 10% of its …
BlockchainCloudMining: Use Bitcoin (BTC), Dogecoin (DOGE) and other cryptocurrencies to start a "stable love" on Mother's Day
GlobeNewswire
·
May 12, 2025
Miami, Florida, May 12, 2025 (GLOBE NEWSWIRE) -- Mother's Day is a warm moment for us to thank our mother for her hard work. In the past, she silently contributed to the family; today, we also hope to give her a "care for continued growth". Nowadays, with …
Fluent, Inc. to Announce 2025 First Quarter Financial Results and Host Earnings Conference Call on May 15, 2025
GlobeNewswire
·
May 12, 2025
NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- Fluent, Inc. (NASDAQ: FLNT) announced today that it will report its financial results for the First Quarter 2025 after the close of the U.S. financial markets on May 15, 2025. Fluent will host a conference call at …
Mine Bitcoin on Your Phone with FioBit: The Best Cloud Mining Tool for Android & iOS to Maximize Crypto Returns
GlobeNewswire
·
May 12, 2025
Sydney, Austrailia, May 12, 2025 (GLOBE NEWSWIRE) -- In 2025, Bitcoin mining is undergoing a significant transformation. With the global Bitcoin network hashrate exceeding 1,124 EH/s (source: CoinWarz), traditional hardware mining is no longer practical …